Dosidal · Singapore

ZINNAT FOR SUSPENSION 125 mg/5 ml

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSingapore
Recordsg:authorisation:SIN07013P (version 1)
Levelauthorisation
Pack codenot anchored
Identifierssg-hsa-licence: SIN07013P
Source authorityHSA
Read date2026-08-07T09:43:28Z
authorisation statuslisting: Listing of Registered Therapeutic Products
registered: True
state: current · read 2026-08-07T09:43:28Z · source: Health Sciences Authority (HSA), via data.gov.sg page
identityapproval_date_as_published: 15/5/1992
atc: J01DC02
country_of_manufacture: UNITED KINGDOM&&AUSTRIA&&CHINA
dosage_form: GRANULE, FOR SUSPENSION
holder: SANDOZ SINGAPORE PTE. LTD.
licence_number: SIN07013P
manufacturer: Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations)&&Sandoz GmbH&&Titan Pharmaceutical Co., Ltd. (Guangdong)
product: ZINNAT FOR SUSPENSION 125 mg/5 ml
route: ORAL
strength: 125 mg/5 ml
substances: CEFUROXIME AXETIL
state: current · read 2026-08-07T09:43:28Z · source: Health Sciences Authority (HSA), via data.gov.sg page
prescription classclass: prescription
forensic_classification: Prescription Only
state: current · read 2026-08-07T09:43:28Z · source: Health Sciences Authority (HSA), via data.gov.sg page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
h4OTeoMiRwESmKLWMd4hRvXU9sReM5AnkiOwnIWpxUKKZBxk5aTOcLpHWHG67sy4ucXeGch4AxouLUN1Vzc6xQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/sg:authorisation:SIN07013P · Same medicine in other markets · Dosidal